Renovacor Inc (RCOR) Stock
RCOR is no longer traded. Renovacor was delisted from the NYSE American in November 2022.
Prices on this page are historical; the last trade was November 30, 2022 at $3.20.
Renovacor stock price history
RCOR final trading statistics
- Final close
- $3.20
- Final trading day
- Nov 30, 2022
- Market cap at delisting
- $55.26M
- Shares outstanding
- 17.27M
- Final 52-week range
- $1.34 – $9.74
- Avg. volume (final 3 mo.)
- 70,682
- All-time high (split-adj.)
- $10.84 · Feb 2021
- All-time low (split-adj.)
- $1.56 · Jun 2022
- Return since IPO
- -67.4%
- Beta
- -0.33
- Book value / share
- $2.55
- Price / book
- 1.26
Renovacor annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $0.00 | -$14.1M | -$1.33 |
| FY2020 | $0.00 | -$780.8K | -$0.41 |
| FY2019 | — | -$520.00 | -$0.50 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Renovacor Inc
Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). The company's lead product candidate is REN-001, a recombinant adeno-associated virus 9-based gene therapy designed to deliver a functional BAG3 gene to augment BAG3 protein levels in cardiomyocytes, and slow or halt progression of BAG3 DCM. It is also developing a pipeline of BAG3-associated gene therapies for diseases with high unmet medical need associated with mutations in the BAG3 gene and mechanistically linked to BAG3's expression and function. The company was founded in 2013 and is based in Greenwich, Connecticut.
Renovacor stock FAQ
What happened to Renovacor stock?
Renovacor stock was delisted from the NYSE American. Its final close was $3.20 on November 30, 2022.
Is RCOR stock still trading?
No. RCOR was delisted from the NYSE American in November 2022 and no longer trades on a U.S. exchange.
What was the last price of RCOR stock?
RCOR closed at $3.20 on its final trading day, November 30, 2022, for a market value of about $55.26M.
What were Renovacor's revenue and earnings in its last full fiscal year?
Renovacor reported revenue of $0.00 and net income of -$14.1M in fiscal 2021, its last full year as a public company.
When did Renovacor go public?
Renovacor Inc stock began trading on June 22, 2020.